First Oral PCSK9 Inhibitor Rivals Injectables


Medscape Medical News

source https://www.medscape.com/viewarticle/oral-pcsk9-inhibitor-provides-ldl-reductions-comparable-2025a1000v03?src=rss

Comments

Popular posts from this blog

New AAFP practice guideline sets blood pressure targets for adults with hypertension

A Large Multicenter Prospective Study of Community-Onset Healthcare Associated Bacteremic Urinary Tract Infections in the Era of Multidrug Resistance: Even Worse than Hospital Acquired Infections?